from my finance advisorAZJ -8.84%:Fell on a weak FY24 result, particularly in terms of the two that count – profitand dividend.
- NPAT +11% to $406m but a 10% miss to consensus of $452m)
- FY24 full year DPS 17cpsm and 11% miss to consensus of 19cps (7.3cps final dividend 60% franked)
- FY25 Guidance was soft, expecting EBITDA of $1,660-1,740m , 3% below consensus
- They did announce a buy back, up to $150m
This isresilient business, but it’s a struggle at the moment and it lacks a catalystin the near term.
- Forums
- ASX - By Stock
- AZJ
- Ann: Full year results presentation
Ann: Full year results presentation, page-16
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AZJ (ASX) to my watchlist
|
|||||
Last
$3.28 |
Change
-0.020(0.61%) |
Mkt cap ! $6.037B |
Open | High | Low | Value | Volume |
$3.28 | $3.31 | $3.16 | $53.21M | 16.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
132 | 230054 | $3.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.29 | 342618 | 103 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
122 | 199247 | 3.280 |
64 | 387610 | 3.270 |
30 | 275869 | 3.260 |
27 | 363689 | 3.250 |
23 | 319777 | 3.240 |
Price($) | Vol. | No. |
---|---|---|
3.290 | 387688 | 99 |
3.300 | 292270 | 47 |
3.310 | 211744 | 20 |
3.320 | 119485 | 17 |
3.330 | 218798 | 9 |
Last trade - 14.58pm 13/08/2024 (20 minute delay) ? |
Featured News
AZJ (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online